Aptose Biosciences Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Toronto
SEC filing record 1 source field available
Fiscal year end
31 December
Aptose Biosciences Inc. has filed 1,073 SEC EDGAR filings since 14 Feb 1997

SEC filing history

Showing 251-275 of 865 matching filings.

Per page
25
Current page
11
4

FORM 4

Filing date
21 Sep 2022
Reporting date
19 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Sep 2022
Reporting date
14 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
16 Sep 2022
Reporting date
13 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jul 2022
Reporting date
06 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Jun 2022
Reporting date
27 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
28 Jun 2022
Reporting date
27 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Jun 2022
Reporting date
31 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-32001

FORM 8-K/A

Filing date
06 Jun 2022
Reporting date
02 Jun 2022
Next action
Verify source filing
4

FORM 4

Filing date
06 Jun 2022
Reporting date
06 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .